Introduction: The objective was to assess the prognostic value of the systolic flow through the aortic isthmus in monochorionic pregnancies complicated by twin-twin transfusion syndrome (TTTS) treated by placental laser ablation. Material and Methods: Fetal echocardiography and outcome data of 105 cases of TTTS treated by laser photocoagulation of placental anastomoses were reviewed. Hemodynamic parameters were collected before and after treatment. The isthmic systolic index (ISI) was calculated as the peak systolic velocity/systolic nadir ratio. Results: A total of 105 laser coagulations were studied. Fetal echocardiography pre- and post-laser were available in 68 cases, including 55 with data on aortic isthmic Doppler. Survival rates were 17, 22, and 61% for 0, 1, or 2 twins, respectively. At least 1 twin was delivered alive in 83% of the pregnancies. The mean gestational age at surgery was 21 weeks (range 16-26). Median ISI values were similar for donor and recipient twins, before and after laser ablation (all p > 0.05). A lower recipient ISI before laser was related to early recipient demise within 24 h (p = 0.04). Discussion: A lower ISI before placental laser ablation for TTTS is associated with postoperative demise of the recipient twin.

1.
Simpson LL: Twin-twin transfusion syndrome. Am J Obstet Gynecol 2013;208:3-18.
2.
Lewi L, Jani J, Blickstein I, Huber A, Gucciardo L, Van Mieghem T, Done E, Boes AS, Hecher K, Gratacos E, Lewi P, Deprest J: The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study. Am J Obstet Gynecol 2008;199:514.e1-e8.
3.
Acosta-Rojas R, Becker J, Munoz-Abellana B, Ruiz C, Carreras E, Gratacos E, Catalunya and Balears Monochorionic Network: Twin chorionicity and the risk of adverse perinatal outcome. Int J Gynaecol Obstet 2007;96:98-102.
4.
Hecher K, Plath H, Bregenzer T, Hansmann M, Hackeloer BJ: Endoscopic laser surgery versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol 1999;180:717-724.
5.
Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y: Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004;351:136-144.
6.
Baschat A, Chmait RH, Deprest J, Gratacos E, Hecher K, Kontopoulos E, Quintero R, Skupski DW, Valsky DV, Ville Y, Consensus Group on Twin-to-Twin Transfusion: Twin-to-twin transfusion syndrome (TTTS). J Perinat Med 2011;39:107-112.
7.
Akkermans J, Peeters SH, Klumper FJ, Lopriore E, Middeldorp JM, Oepkes D: Twenty-five years of fetoscopic laser coagulation in twin-twin transfusion syndrome: a systematic review. Fetal Diagn Ther 2015;38:241-253.
8.
Muratore CS, Carr SR, Lewi L, Delieger R, Carpenter M, Jani J, Deprest JA, Luks FI: Survival after laser surgery for twin-to-twin transfusion syndrome: when are they out of the woods? J Pediatr Surg 2009;44:66-69; discussion 70.
9.
Persico N, Fabietti I, D'Ambrosi F, Riccardi M, Boito S, Fedele L: Postnatal survival after endoscopic equatorial laser for the treatment of twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2016;214:533.e1-7.
10.
Yamamoto M, Ville Y: Laser treatment in twin-to-twin transfusion syndrome. Semin Fetal Neonatal Med 2007;12:450-457.
11.
Shah AD, Border WL, Crombleholme TM, Michelfelder EC: Initial fetal cardiovascular profile score predicts recipient twin outcome in twin-twin transfusion syndrome. J Am Soc Echocardiogr 2008;21:1105-1108.
12.
Zikulnig L, Hecher K, Bregenzer T, Baz E, Hackeloer BJ: Prognostic factors in severe twin-twin transfusion syndrome treated by endoscopic laser surgery. Ultrasound Obstet Gynecol 1999;14:380-387.
13.
Rychik J, Tian Z, Bebbington M, Xu F, McCann M, Mann S, Wilson RD, Johnson MP: The twin-twin transfusion syndrome: spectrum of cardiovascular abnormality and development of a cardiovascular score to assess severity of disease. Am J Obstet Gynecol 2007;197:392.e1-8.
14.
Skupski DW, Luks FI, Walker M, Papanna R, Bebbington M, Ryan G, O'Shaughnessy R, Moldenhauer J, Bahtiyar O, North American Fetal Therapy Network: Preoperative predictors of death in twin-to-twin transfusion syndrome treated with laser ablation of placental anastomoses. Am J Obstet Gynecol 2010;203:388.e1-388.e11.
15.
Stirnemann JJ, Nasr B, Proulx F, Essaoui M, Ville Y: Evaluation of the CHOP cardiovascular score as a prognostic predictor of outcome in twin-twin transfusion syndrome after laser coagulation of placental vessels in a prospective cohort. Ultrasound Obstet Gynecol 2010;36:52-57.
16.
Papanna R, Mann LK, Molina S, Johnson A, Moise KJ: Changes in the recipient fetal Tei index in the peri-operative period after laser photocoagulation of placental anastomoses for twin-twin transfusion syndrome. Prenat Diagn 2011;31:176-180.
17.
Gapp-Born E, Sananes N, Weingertner AS, Guerra F, Kohler M, Fritz G, Viville B, Gaudineau A, Langer B, Sauleau E, Nisand I, Favre R: Predictive value of cardiovascular parameters in twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 2014;44:427-433.
18.
Eschbach SJ, Boons LS, Wolterbeek R, Middeldorp JM, Klumper FJ, Lopriore E, Oepkes D, Haak MC: Prediction of single fetal demise after laser therapy for twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 2016;47:356-362.
19.
Bonnin P, Fouron JC, Teyssier G, Sonesson SE, Skoll A: Quantitative assessment of circulatory changes in the fetal aortic isthmus during progressive increase of resistance to umbilical blood flow. Circulation 1993;88:216-222.
20.
Fouron JC, Zarelli M, Drblik P, Lessard M: Flow velocity profile of the fetal aortic isthmus through normal gestation. Am J Cardiol 1994;74:483-486.
21.
Makikallio K, Jouppila P, Rasanen J: Retrograde net blood flow in the aortic isthmus in relation to human fetal arterial and venous circulations. Ultrasound Obstet Gynecol 2002;19:147-152.
22.
Del Rio M, Martinez JM, Figueras F, Bennasar M, Olivella A, Palacio M, Coll O, Puerto B, Gratacos E: Doppler assessment of the aortic isthmus and perinatal outcome in preterm fetuses with severe intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:41-47.
23.
Acharya G, Tronnes A, Rasanen J: Aortic isthmus and cardiac monitoring of the growth-restricted fetus. Clin Perinatol 2011;38:113-125, vi-vii.
24.
Fouron JC: The unrecognized physiological and clinical significance of the fetal aortic isthmus. Ultrasound Obstet Gynecol 2003;22:441-447.
25.
Tynan D, Alphonse J, Henry A, Welsh AW: The aortic isthmus: a significant yet underexplored watershed of the fetal circulation. Fetal Diagn Ther 2016;40:81-93.
26.
Chabaneix J, Fouron JC, Sosa-Olavarria A, Gendron R, Dahdah N, Berger A, Brisebois S: Profiling left and right ventricular proportional output during fetal life with a novel systolic index in the aortic isthmus. Ultrasound Obstet Gynecol 2014;44:176-181.
27.
Kenny JF, Plappert T, Doubilet P, Saltzman DH, Cartier M, Zollars L, Leatherman GF, St John Sutton MG: Changes in intracardiac blood flow velocities and right and left ventricular stroke volumes with gestational age in the normal human fetus: a prospective Doppler echocardiographic study. Circulation 1986;74:1208-1216.
28.
Raboisson MJ, Fouron JC, Lamoureux J, Leduc L, Grignon A, Proulx F, Gamache S: Early intertwin differences in myocardial performance during the twin-to-twin transfusion syndrome. Circulation 2004;110:3043-3048.
29.
Delabaere A, Leduc F, Reboul Q, Fuchs F, Wavrant S, Fouron JC, Audibert F: Prediction of neonatal outcome of TTTS by fetal heart and Doppler ultrasound parameters before and after laser treatment. Prenat Diagn 2016;36:1199-1205.
30.
Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M: Staging of twin-twin transfusion syndrome. J Perinatol 1999;19:550-555.
31.
Moise KJ Jr, Johnson A, Bebbington MW, Papanna R: The ‘Solomon method'. Ultrasound Obstet Gynecol 2014;43:238-239.
32.
American Institute of Ultrasound in Medicine: AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med 2013;32:1067-1082.
33.
Rychik J, Ayres N, Cuneo B, Gotteiner N, Hornberger L, Spevak PJ, Van Der Veld M: American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 2004;17:803-810.
34.
Raboisson MJ, Bourdages M, Fouron JC: Measuring left ventricular myocardial performance index in fetuses. Am J Cardiol 2003;91:919-921.
35.
Hernandez-Andrade E, Lopez-Tenorio J, Figueroa-Diesel H, Sanin-Blair J, Carreras E, Cabero L, Gratacos E: A modified myocardial performance (Tei) index based on the use of valve clicks improves reproducibility of fetal left cardiac function assessment. Ultrasound Obstet Gynecol 2005;26:227-232.
36.
Fouron JC, Gosselin J, Raboisson MJ, Lamoureux J, Tison CA, Fouron C, Hudon L: The relationship between an aortic isthmus blood flow velocity index and the postnatal neurodevelopmental status of fetuses with placental circulatory insufficiency. Am J Obstet Gynecol 2005;192:497-503.
37.
Johnson MP, NAFTNet: The North American Fetal Therapy Network (NAFTNet): a new approach to collaborative research in fetal diagnosis and therapy. Semin Fetal Neonatal Med 2010;15:52-57.
38.
Kim SY, Lee SP, Lee CM, Jung SY, Park HN: Doppler assessment of fetal aortic isthmus flow in twin. Obstet Gynecol Sci 2015;58:17-23.
39.
Mahieu-Caputo D, Meulemans A, Martinovic J, Gubler MC, Delezoide AL, Muller F, Madelenat P, Fisk NM, Dommergues M: Paradoxic activation of the renin-angiotensin system in twin-twin transfusion syndrome: an explanation for cardiovascular disturbances in the recipient. Pediatr Res 2005;58:685-688.
40.
Mercanti I, Boivin A, Wo B, Vlieghe V, Le Ray C, Audibert F, Fouron JC, Leduc L, Nuyt AM: Blood pressures in newborns with twin-twin transfusion syndrome. J Perinatol 2011;31:417-424.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.